Predictive biomarkers for checkpoint inhibitor-based immunotherapy.

MLA

Gibney, Geoffrey T., et al. “Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy.” The Lancet. Oncology, vol. 17, no. 12, Dec. 2016, pp. e542–51. EBSCOhost, https://doi.org/10.1016/S1470-2045(16)30406-5.

APA

Gibney, G. T., Weiner, L. M., & Atkins, M. B. (2016). Predictive biomarkers for checkpoint inhibitor-based immunotherapy. The Lancet. Oncology, 17(12), e542–e551. https://doi.org/10.1016/S1470-2045(16)30406-5

Chicago

Gibney, Geoffrey T, Louis M Weiner, and Michael B Atkins. 2016. “Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy.” The Lancet. Oncology 17 (12): e542–51. doi:10.1016/S1470-2045(16)30406-5.